We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+7.06%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$2.66B
AUM Growth
+$447M
(+20%)
Cap. Flow
+$395M
Cap. Flow
% of AUM
14.87%
Top 10 Holdings %
Top 10 Hldgs %
18.05%
Holding
1,302
New
172
Increased
969
Reduced
51
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$18.9M |
| 2 |
Microsoft
MSFT
|
+$13.5M |
| 3 |
Apple
AAPL
|
+$12.1M |
| 4 |
ExxonMobil
XOM
|
+$7.45M |
| 5 |
Meta Platforms (Facebook)
META
|
+$7.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$7.2M |
| 2 |
Medtronic
MDT
|
+$5.4M |
| 3 |
Accenture
ACN
|
+$4.98M |
| 4 |
SLB Ltd
SLB
|
+$4.33M |
| 5 |
LyondellBasell Industries
LYB
|
+$4.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Healthcare | 13.73% |
| 3 | Consumer Discretionary | 11.89% |
| 4 | Financials | 11.87% |
| 5 | Industrials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
976
DELISTED
Loxo Oncology, Inc
LOXO
| $255K | 0.01% |
+1,492
| New | +$251K |
|
977
Buckle
BKE
$2.19B
| $253K | 0.01% |
10,973
+7,684
| +234% | +$189K |
|
|
FOLD
978
DELISTED
Amicus Therapeutics
FOLD
| $252K | 0.01% |
+20,810
| New | +$291K |
|
|
ARNA
979
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $252K | 0.01% |
+5,473
| New | +$222K |
|
|
TDAY
980
USA Today Co
TDAY
$1.23B
| $251K | 0.01% |
16,024
+11,155
| +229% | +$187K |
|
981
Puma Biotechnology
PBYI
$406M
| $251K | 0.01% |
+5,468
| New | +$264K |
|
|
MGLN
982
DELISTED
Magellan Health Services, Inc.
MGLN
| $249K | 0.01% |
3,449
+1,601
| +87% | +$129K |
|
|
CSOD
983
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $249K | 0.01% |
+4,385
| New | +$237K |
|
|
KYNB
984
Kyntra Bio
KYNB
$28.5M
| $246K | 0.01% |
+162
| New | +$249K |
|
|
SRCL
985
DELISTED
Stericycle Inc
SRCL
| $245K | 0.01% |
4,175
+510
| +14% | +$32.6K |
|
|
BLUE
986
DELISTED
bluebird bio
BLUE
| $244K | 0.01% |
+129
| New | +$266K |
|
987
Under Armour
UAA
$3B
| $241K | 0.01% |
11,346
+2,697
| +31% | +$56.2K |
|
988
Box
BOX
$4.02B
| $240K | 0.01% |
+10,041
| New | +$253K |
|
989
Tredegar Corp
TG
$268M
| $240K | 0.01% |
11,095
+8,834
| +391% | +$202K |
|
990
MaxLinear
MXL
$6.49B
| $239K | 0.01% |
+12,033
| New | +$219K |
|
991
Editas Medicine
EDIT
$399M
| $237K | 0.01% |
+7,434
| New | +$240K |
|
|
P
992
DELISTED
Pandora Media Inc
P
| $237K | 0.01% |
+24,954
| New | +$210K |
|
993
Myriad Genetics
MYGN
$530M
| $236K | 0.01% |
+5,140
| New | +$229K |
|
994
Mativ Holdings
MATV
$448M
| $234K | 0.01% |
6,105
+4,017
| +192% | +$167K |
|
|
SAGE
995
DELISTED
Sage Therapeutics
SAGE
| $233K | 0.01% |
+1,653
| New | +$255K |
|
996
Tenaris
TS
$29.1B
| $232K | 0.01% |
6,918
-2,249
| -25% | -$78K |
|
997
Alnylam Pharmaceuticals
ALNY
$36.3B
| $231K | 0.01% |
+2,640
| New | +$266K |
|
998
Madrigal Pharmaceuticals
MDGL
$12.6B
| $231K | 0.01% |
+1,078
| New | +$271K |
|
999
Enanta Pharmaceuticals
ENTA
$372M
| $230K | 0.01% |
+2,693
| New | +$270K |
|
1000
Upbound Group
UPBD
$1.19B
| $230K | 0.01% |
15,993
+8,811
| +123% | +$129K |
|
Similar funds
SAM
Pacer Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Pacer Advisors held 1,302 positions worth $2.66B, up 20% from $2.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Pacer Advisors deployed $395M of net new capital in Q3 2018, opening 172 new positions and adding to 969 existing holdings. Its largest new stake was VMware, Inc: 19,828 shares worth $3.09M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $3.26M trimmed.
- Pacer Advisors's largest Q3 2018 buy was VMware, Inc: 19,828 shares worth $3.09M.
- Pacer Advisors added most to Amazon in Q3 2018, an estimated $18.9M increase.
- Pacer Advisors's biggest Q3 2018 reduction was Wellcare Health Plans, Inc., cutting an estimated $3.26M.
- Pacer Advisors fully exited BASF AKTIENGESELLT ADS(RP1 ORD in Q3 2018, selling an estimated $7.2M.
- Pacer Advisors's ten largest holdings make up 18% of its $2.66B portfolio in Q3 2018.
- Pacer Advisors opened 172 new positions and closed 109 in Q3 2018.
- Pacer Advisors's portfolio value rose 20% quarter-over-quarter to $2.66B.
Based on Pacer Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.